Trial Profile
Direct comparison of TOfogliflozin and iPragliflozin on hyper-hypoglycemia using Continuous Glucose Monitoring system (TOP-CGM)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary) ; Tofogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TOP-CGM
- 11 Jun 2019 Results assessing impact of Tofogliflozin and ipragliflozin on hypoglycemia in patients with Type-2-diabetes-mellitus presented at the 79th Annual Scientific Sessions of the American Diabetes Association.
- 14 Jul 2015 New trial record